CompanyGraph
At a glance
- Depends onMidstream position: 5 outgoing, 4 incoming connections
- ScaleRevenue is $743.78M, above the global median of $520.53M
- FinancialsAltman Z-Score 2.66: safe zone
- Interpretations1 currently firing — 1
Sign in to view price data.
Sign inWhat the company actually pays, and whether its own cash supports it.
Dividends view
Yield
1.75%Above 5Y avg (1.07%)
Annual Rate
KRW 160.00Paid annual
Payout Ratio
11.2%Sustainable
Payback Period
55.9 yr
Last Ex-Dividend
Dec 29, 2025
The reported statements, read against the company's own industry.
Financials view
Market Capitalization
773.00BKRW556.99M · vs all stocks (USD)
Trailing P/E
11.95xRevenue (TTM)
1.03TKRW743.78M · vs all stocks (USD)
Profit Margin
10.21%Beta
0.3040xvs all stocks
52-Week Change
11.31%vs all stocks
Market Capitalization
773.00BKRW556.99M · vs all stocks (USD)
Enterprise Value
783.45BKRW564.52M · vs all stocks (USD)
Trailing P/E
11.95xForward P/E
11.51xPEG Ratio
0.0010xPrice to Sales (TTM)
0.7358xPrice to Book (MRQ)
0.8793xEnterprise to Revenue
0.7590xEnterprise to EBITDA
6.61xGross Margin
37.04%Profit Margin
10.21%Operating Margin
7.89%Return on Assets (TTM)
3.68%Return on Equity (TTM)
12.78%Revenue (TTM)
1.03TKRW743.78M · vs all stocks (USD)
Revenue per Share (TTM)
12.29KKRWUpdated Aug 20, 2026Quarterly Revenue Growth
6.20%Gross Profit (TTM)
380.08BKRW273.87M · vs all stocks (USD)
EBITDA (TTM)
235.17BKRW169.45M · vs all stocks (USD)
Net Income (TTM)
105.39BKRW75.94M · vs all stocks (USD)
Quarterly Earnings Growth (YoY)
11762.40%Operating Cash Flow (TTM)
158.63BKRW114.30M · vs all stocks (USD)
Levered Free Cash Flow (TTM)
84.85BKRW61.14M · vs all stocks (USD)
Trailing Annual Dividend Rate
160.00KRWUpdated Aug 20, 2026Trailing Annual Dividend Yield
1.75%vs all stocks
5-Year Average Dividend Yield
1.07%vs all stocks
Payout Ratio
11.18%Revenue
1.02TKRWFY2025 · Dec 31, 2025Cost of Goods Sold
645.14BKRWFY2025 · Dec 31, 2025Gross Profit
372.28BKRWFY2025 · Dec 31, 2025Operating Income
65.07BKRW46.88M · vs all stocks (USD)
Pre-tax Income
69.85BKRWFY2025 · Dec 31, 2025Income Tax Expense
5.55BKRWFY2025 · Dec 31, 2025Net Income
64.30BKRWFY2025 · Dec 31, 2025EBIT
81.42BKRWFY2025 · Dec 31, 2025EBITDA (Income Statement)
113.38BKRWFY2025 · Dec 31, 2025Research & Development
65.09BKRWFY2025 · Dec 31, 2025Selling, General & Administrative
99.58BKRWFY2025 · Dec 31, 2025Other Operating Expenses
5.98BKRWFY2025 · Dec 31, 2025Non-operating Interest Income
8.56BKRWFY2025 · Dec 31, 2025Non-operating Interest Expense
11.58BKRWFY2025 · Dec 31, 2025EPS (Basic)
766.00KRWFY2025 · Dec 31, 2025EPS (Diluted)
766.00KRWFY2025 · Dec 31, 2025Basic Shares Outstanding
83.95MSharesFY2025 · Dec 31, 2025Diluted Shares Outstanding
83.95MSharesFY2025 · Dec 31, 2025Net Income from Continuing Operations
64.30BKRWFY2025 · Dec 31, 2025Operating Cash Flow
93.61BKRWFY2025 · Dec 31, 2025Free Cash Flow
71.39BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents (End of Period)
227.61BKRWFY2025 · Dec 31, 2025Starting Profit (CF Statement)
64.30BKRWFY2025 · Dec 31, 2025Stock-based Compensation
-75.80MKRWFY2025 · Dec 31, 2025Other Non-cash Items
3.25BKRWFY2025 · Dec 31, 2025Change in Accounts Receivable (CF)
17.21BKRWFY2025 · Dec 31, 2025Change in Other Assets/Liabilities
8.92BKRWFY2025 · Dec 31, 2025Capital Expenditures
-22.22BKRWFY2025 · Dec 31, 2025Net Intangibles (CF)
-7.65BKRWFY2025 · Dec 31, 2025Purchase of Investments
-25.15BKRWFY2025 · Dec 31, 2025Sale of Investments
4.67BKRWFY2025 · Dec 31, 2025Other Investing Activity
-176.35BKRWFY2025 · Dec 31, 2025Net Investing Cash Flow
-219.04BKRWFY2025 · Dec 31, 2025Long-term Debt Issuance
199.37BKRWFY2025 · Dec 31, 2025Long-term Debt Payments
-78.08BKRWFY2025 · Dec 31, 2025Net Short-term Debt Issuance
-3.33BKRWFY2025 · Dec 31, 2025Common Dividends Paid
-8.40BKRWFY2025 · Dec 31, 2025Other Financing Charges
-13.43MKRWFY2025 · Dec 31, 2025Net Financing Cash Flow
109.55BKRWFY2025 · Dec 31, 2025Shares Outstanding
84.48MSharesUpdated Aug 20, 2026Float Shares
28.50MSharesUpdated Aug 20, 2026% Held by Insiders
65.77%vs all stocks
% Held by Institutions
6.36%vs all stocks
Total Cash (MRQ)
263.94BKRW190.18M · vs all stocks (USD)
Total Cash per Share (MRQ)
3.12KKRWUpdated Aug 20, 2026Total Debt (MRQ)
287.90BKRW207.45M · vs all stocks (USD)
Total Debt to Equity (MRQ)
0.3295xCurrent Ratio (MRQ)
2.62xBook Value per Share (MRQ)
10.41KKRWUpdated Aug 20, 2026Total Assets
1.39TKRW1.00B · vs all stocks (USD)
Total Current Assets
662.94BKRWFY2025 · Dec 31, 2025Total Liabilities
542.38BKRWFY2025 · Dec 31, 2025Total Non-current Assets
724.94BKRWFY2025 · Dec 31, 2025Total Non-current Liabilities
287.41BKRWFY2025 · Dec 31, 2025Total Current Liabilities
254.97BKRWFY2025 · Dec 31, 2025Cash Equivalents
227.61BKRWFY2025 · Dec 31, 2025Cash & Cash Equivalents
227.61BKRWFY2025 · Dec 31, 2025Other Short-term Investments
27.07BKRWFY2025 · Dec 31, 2025Accounts Receivable
168.44BKRWFY2025 · Dec 31, 2025Inventory
219.44BKRWFY2025 · Dec 31, 2025Accounts Payable
98.52BKRWFY2025 · Dec 31, 2025Short-term Debt
70.92BKRWFY2025 · Dec 31, 2025Other Current Liabilities
25.32BKRWFY2025 · Dec 31, 2025Long-term Debt
259.10BKRWFY2025 · Dec 31, 2025Other Non-current Liabilities
4.54BKRWFY2025 · Dec 31, 2025Common Stock (Book)
43.39BKRWFY2025 · Dec 31, 2025Retained Earnings
518.81BKRWFY2025 · Dec 31, 2025Total Shareholders' Equity
845.50BKRW609.24M · vs all stocks (USD)
Treasury Stock
16.80BKRWFY2025 · Dec 31, 202552-Week Low
7.41KKRWUpdated Aug 20, 202652-Week High
10.80KKRWUpdated Aug 20, 202652-Week Change
11.31%vs all stocks
Beta
0.3040xvs all stocks
50-Day MA
8.50KKRWUpdated Aug 20, 2026200-Day MA
9.09KKRWUpdated Aug 20, 2026Avg 10-Day Volume
97.86KSharesUpdated Aug 20, 2026Avg 30-Day Volume
107.76KSharesUpdated Aug 20, 2026Diluted EPS (TTM)
766.00KRWUpdated Aug 20, 20261 interpretation currently present — each is a set of fired observations whose alignment reads as one structural pattern. Click an observation to see the numbers behind it.
Screen for these patternsIs this company growing?
Multi-Year Revenue, Profit, And Income Growth
Revenue has risen in each of three years, gross profit in each of four, and it has made a profit in all five.
Reads
An interpretation is present only while every observation it reads stays fired (score ≥ 70). It describes what the aligned readings show — never a verdict, never a prediction.
Shared structure with peers — never a ranking.
Relationships view
Structural observations derived from financial data, industry benchmarks, and supply chain position.
Financial Health
Altman Z-Score 2.66: safe zoneNotable
Altman Z-Score: 2.66
Supply Chain
Midstream position: 5 outgoing, 4 incoming connectionsNotable
Outgoing: 5.00Incoming: 4.00
Scale
Revenue is $743.78M, above the global median of $520.53MNotable
Revenue (USD): 743,784,553.869Global Median: 520,528,949.311
Levered free cash flow is $61.14M, above the global median of $16.24MNotable
Levered free cash flow (USD): 61,136,517.271Global Median: 16,239,329.704
Companies that share the same coordination system — how they create, deliver, or capture value.
Assure Tech Hangzhou Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Orchid Pharma Ltd.
Tier 1ProductionApproval-Gated PipelineRule
CHA Biotech Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleInterface
Altimmune, Inc.
Tier 1ProductionApproval-Gated PipelineRule
Shaanxi Kanghui Pharmaceutical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Shandong Sinobioway Biomedicine Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Wuhan Hiteck Biological Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Kingchem Liaoning Life Science Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Jiangsu Sihuan Bioengineering Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRuleFlow
Careray Digital Medical Co., Ltd.
Tier 1ProductionApproval-Gated PipelineRule
Companies that share active interpretations — structural patterns currently present in both stocks.
Multiplan Empreendimentos Imobiliários S.A.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Mueller Water Products Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth
Neurocrine Biosciences Inc.
1 interpretationMulti-Year Revenue, Profit, And Income Growth